Crinetics Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q3 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Operating Lease, Payments history and growth rate from Q3 2021 to Q3 2022.
  • Crinetics Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2022 was $300K, a 66.7% decline year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $300K -$600K -66.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q3 2021 $900K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.